These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24592955)

  • 1. Orally inhaled fixed-dose combination products for the treatment of asthma and chronic obstructive pulmonary disease: not simple math.
    Ehrick JD; Wylie J; Goodey AP; Li Y; Liu O; Donovan B
    Ther Deliv; 2014 Mar; 5(3):297-317. PubMed ID: 24592955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry powder inhalers: an overview.
    Atkins PJ
    Respir Care; 2005 Oct; 50(10):1304-12; discussion 1312. PubMed ID: 16185366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Easyhaler--ideal dry powder inhaler].
    Andrzej E; Małgorzata BE
    Pol Merkur Lekarski; 2010 Apr; 28(166):307-10. PubMed ID: 20491343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities in respiratory drug delivery.
    Pritchard JN; Giles RD
    Ther Deliv; 2014 Dec; 5(12):1261-73. PubMed ID: 25531928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of inhalation therapy in chronic obstructive pulmonary disease and asthma.
    Pavia D
    Respirology; 1997; 2 Suppl 1():S5-10. PubMed ID: 9400688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress of research on pressurized metered dose inhalers].
    Zhou X
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147
    [No Abstract]   [Full Text] [Related]  

  • 9. Developments in inhaled combination therapies: patent activity 2013-2014.
    Norman P
    Expert Opin Ther Pat; 2015; 25(11):1239-45. PubMed ID: 26135360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fixed-dose combination of proven active ingredients in new inhaler].
    Koczorek M
    Med Monatsschr Pharm; 2014 Sep; 37(9):341-2. PubMed ID: 25282752
    [No Abstract]   [Full Text] [Related]  

  • 11. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch.
    Tamura G; Ohta K
    Respir Med; 2007 Sep; 101(9):1895-902. PubMed ID: 17587559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
    Tamm M; Richards DH; Beghé B; Fabbri L
    Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhaled therapy via nebulization: practical issues].
    Antoniu S; Bararu T; Zizilaş G; Mihăescu T
    Pneumologia; 2007; 56(3):143-6. PubMed ID: 18019975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of inhaler devices in the management of airway disease.
    Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
    Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [User friendly inhalation system. Relief for asthmatic patients].
    MMW Fortschr Med; 2002 Sep; 144(39):52. PubMed ID: 12422694
    [No Abstract]   [Full Text] [Related]  

  • 18. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.
    Buhl R; Farmer SG
    Proc Am Thorac Soc; 2004; 1(2):136-42. PubMed ID: 16113426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in inhaler devices for asthma and COPD.
    Capriotti T
    Medsurg Nurs; 2005 Jun; 14(3):185-94. PubMed ID: 16035636
    [No Abstract]   [Full Text] [Related]  

  • 20. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
    Adi H; Young PM; Traini D
    J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.